APLT
Applied Therapeutics Inc
NASDAQ: APLT · HEALTHCARE · BIOTECHNOLOGY
$0.10
+0.00% today
Updated 2026-04-29
Market cap
$14.86M
P/E ratio
—
P/S ratio
14.86x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $2
Volume
2.7M
Applied Therapeutics Inc (APLT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,797.00%
ROE
-680.00%
ROA
-88.30%
Debt/equity
-4.46x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-4.28M | — | — | — |
| 2018 | $0.00 | $-16.52M | — | — | — |
| 2019 | $0.00 | $-45.40M | — | — | — |
| 2020 | $0.00 | $-93.02M | — | — | — |
| 2021 | $0.00 | $-104.61M | — | — | — |
| 2022 | $10.66M | $-82.51M | -4.14% | -778.14% | -774.00% |
| 2023 | $9.99M | $-119.76M | -439.43% | -645.80% | -1,198.47% |
| 2024 | $455000.00 | $-105.62M | -10,612.97% | -22,922.86% | -23,214.07% |